Mevacor (lovastatin)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Mevacor (lovastatin), covering 2026-02-11 to 2026-02-11. Get the full timeline:
Most recent: Clinical Trial Update: Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial [Phase 2]